|Steve Skillman, managing director, corporate foreign exchange, RBS|
There are arguments to be made for all these approaches but, for the purposes of this article, well focus on forward points associated with currency hedging. The benefits of this method include that it avoids the complexity and data intensive approach involved with currency options and aligns with the most common hedging instrument the FX forward contract. This is particularly relevant given the current global economic backdrop. As talk of Federal Open Market Committee tapering increased, the US yield curve has steepened dramatically. Meanwhile, rates in most emerging markets have increased even more significantly. For example, our electronic trading platform RBSMarketplace shows that, since January 2013, the annualised cost of hedging the US dollar against the Indian rupee (INR) has increased from 5.4 per cent to 8.9 per cent, and for the Brazilian real (BRL) from 5.1 per cent to 8.7 per cent. Its important for risk managers to examine this change in interest rates. That is to say, once the hedge cost has been defined it must be quantified. One additional variable to consider is volatility. The more volatile markets are, the greater the risk is to the business and the stronger the desire is to hedge. If markets didnt move, arguably you wouldnt need to hedge at all. The dilemma is: as volatility increases the desire to hedge increases, but so does the cost of hedging. Options become more expensive and rate differentials are wider. During the financial crisis, companies started questioning whether the cost of placing a derivative contract was worth it. Those conversations continue today. Once defined and quantified, hedge costs need to be minimised in a manner consistent with a companys overall risk management policy and philosophy. Given that most multinationals do not speculate in currency markets, the objective becomes protecting the business plan at the lowest possible cost. This process invariably involves data analysis, back testing and scenario analysis to enhance the decision-making process and determine which instrument most effectively reduces hedging costs but still provides protection against a devaluation. In high-cost currencies like the rupee or the real, a random-walk model of future FX rates implies the likelihood of generating a hedge loss may be as high as 75 per cent, which begs the question: why would a company place a hedge contract when it is almost certain to lose money? There are two reasons. First, the company may have a hedge at all costs approach toward risk management. Second, the hedge program may be ingrained and not actively reviewed on a regular basis. Active comparison of hedge costs across forward contracts and purchased options can yield powerful results. Numerous RBS studies, including Monte Carlo simulations multiple trial runs using different variables and back testing have been conducted over periods examining as much as 10 years of data. They yielded results in a variety of currency pairs showing that at-the-money forward options can reduce expected hedging costs by as much as 40 per cent. This area certainly requires a great deal of thought and should be communicated up the chain within the treasury department and the companys business units. Everyone involved should know exactly how and when currency risk will be managed. This takes time to get absolutely right and commitment to make sure it happens. And even when it does happen, there will always be times when you wish you had hedged differently depending on market movements. Theres no such thing as nirvana when it comes to currency risk management. But businesses that see this through will have built firm foundations on which they can better protect their margins at a cost that is well understood and proactively managed.
Disclaimer This communication has been prepared by The Royal Bank of Scotland N.V., The Royal Bank of Scotland plc or an affiliated entity (RBS). This material should be regarded as a marketing communication and has not been prepared in accordance with the legal and regulatory requirements to promote the independence of research and may have been produced in conjunction with the RBS trading desks that trade as principal in the instruments mentioned herein. This commentary is therefore not independent from the proprietary interests of RBS, which may conflict with your interests. Opinions expressed may differ from the opinions expressed by other divisions of RBS including our investment research department. This material includes references to securities and related derivatives that the firms trading desk may make a market in, and in which it is likely as principal to have a long or short position at any time, including possibly a position that was accumulated on the basis of this analysis material prior to its dissemination. Trading desks may also have or take positions inconsistent with this material. This material may have been made available to other clients of RBS before it has been made available to you and regulatory restrictions on RBS dealing in any financial instruments mentioned at any time before is distributed to you do not apply. This document has been prepared for information purposes only. This document has been prepared on the basis of publicly available information believed to be reliable but no representation, warranty or assurance of any kind, express or implied, is made as to the accuracy or completeness of the information contained herein and RBS and each of their respective affiliates disclaim all liability for any use you or any other party may make of the contents of this document. This document is current as of the indicated date and the contents of this document are subject to change without notice. RBS does not accept any obligation to any recipient to update or correct any such information. Views expressed herein are not intended to be and should not be viewed as advice or as a recommendation. RBS makes no representation and gives no advice in respect of any tax, legal or accounting matters in any applicable jurisdiction. You should make your own independent evaluation of the relevance and adequacy of the information contained in this document and make such other investigations as you deem necessary, including obtaining independent financial advice, before participating in any transaction in respect of the securities referred to in this document. This document is not intended for distribution to, or use by any person or entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation. The information contained herein is proprietary to RBS and is being provided to selected recipients and may not be given (in whole or in part) or otherwise distributed to any other third party without the prior written consent of RBS. RBS and its respective affiliates, connected companies, employees or clients may have an interest in financial instruments of the type described in this document and/or in related financial instruments. Such interest may include dealing in, trading, holding or acting as market-makers in such instruments and may include providing banking, credit and other financial services to any company or issuer of securities or financial instruments referred to herein. This marketing communication is intended for distribution only to major institutional investors as defined in Rule 15a-6(a)(2) of the U.S. Securities Act 1934 (excluding documents produced by our affiliates within the U.S.). Any U.S. recipient wanting further information or to effect any transaction related to this trade idea must contact RBS Securities Inc., 600 Washington Boulevard, Stamford, CT, USA. Telephone: +1 203 897 2700. In Singapore, this marketing communication is intended for distribution only to institutional investors (as defined in Section 4A(1) of the Securities and Futures Act (Cap. 289) of Singapore). In Hong Kong, this marketing communication is intended for distribution only to Professional Investors (as defined in Schedule 1 of the Securities and Futures Ordinance of Hong Kong). Issuers mentioned in any material may be investment banking clients of RBS Securities Inc. and RBS Securities Inc. may have provided in the past, and may provide in the future, financing, advice, and securitization and underwriting services to these clients in connection with which it has received or will receive compensation. Accordingly, information included in or excluded from this material is not independent from the proprietary interests of RBS Securities, Inc., which may conflict with your interests. For further information relating to materials provided by RBS, please view our RBSMarketplace Terms and Conditions: RBSM Terms and Conditions The Royal Bank of Scotland plc. Registered in Scotland No. 90312. Registered Office: 36 St Andrew Square, Edinburgh EH2 2YB. The Royal Bank of Scotland plc is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority. The Royal Bank of Scotland N.V., established in Amsterdam, The Netherlands. Registered with the Chamber of Commerce in The Netherlands, No. 33002587. Authorised by De Nederlandsche Bank N.V. and regulated by the Authority for the Financial Markets in The Netherlands. The Royal Bank of Scotland plc is in certain jurisdictions an authorised agent of The Royal Bank of Scotland N.V. and The Royal Bank of Scotland N.V. is in certain jurisdictions an authorised agent of The Royal Bank of Scotland plc. Copyright © 2013 The Royal Bank of Scotland plc. All rights reserved. This communication is for the use of intended recipients only and the contents may not be reproduced, redistributed, or copied in whole or in part for any purpose without The Royal Bank of Scotland plcs prior express consent. Copyright © 2013 RBS Securities Inc. All rights reserved. RBS Securities Inc. member FINRA (http://www.finra.org) / SIPC (http://www.sipc.org), is a subsidiary of The Royal Bank of Scotland plc. RBS is the marketing name for the securities business of RBS Securities Inc